The expression of survivin was, however, statistical significantly lower in non-recurrent meningiomas compared with recurrent tumors with median LI’s of 0.5 and 0.8, respectively (P = 0.035) (Fig 3). This evidence concerns the gene BIRC5 and meningioma.